Skip to main content
Premium Trial:

Request an Annual Quote

UCB Deploys Genedata's Software to Support Drug Programs

NEW YORK (GenomeWeb News) — Belgian biopharmaceutical company UCB is using two of Genedata's software platforms to support its drug-development programs, Genedata said today.
Genedata said UCB has deployed the integrated Phylosopher and Expressionist software platforms. The drug maker will use the platforms to study CNS disorders, allergy and respiratory diseases, immune and inflammatory disorders, and oncology.
Expressionist, which is used in biomarker research, is a modular enterprise system that includes public and private data and sample information.
Phylosopher, meantime, integrates proprietary information with public data and links information such as genome sequences and transcriptomic, proteomic, and metabolomic data with functional information and annotations. It also links phenotypes relevant to disease.
Financial terms of the agreement were not released.

Filed under

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.